Kyverna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	56.87	96.62	34.65	37.74	76.07
Short-Term Investments	185.78	189.36	22.9	13.59	-
Cash & Short-Term Investments	242.65	285.98	57.54	51.32	76.07
Cash Growth	321.68%	396.98%	12.12%	-32.53%	-
Prepaid Expenses	5	4.62	3.12	1.93	1.02
Total Current Assets	247.65	290.6	60.66	53.25	77.09
Property, Plant & Equipment	8.8	10.66	10.61	12.44	7.81
Long-Term Deferred Charges	-	-	2.5	-	-
Other Long-Term Assets	4.2	3.39	1.42	1.23	0.59
Total Assets	260.66	304.65	75.2	66.92	85.49
Accounts Payable	8.47	4.62	4.36	1.45	0.77
Accrued Expenses	9.33	11.13	9.06	7.66	7.77
Current Portion of Leases	3.59	3.94	2.92	2.28	0.81
Current Unearned Revenue	-	-	-	-	6
Other Current Liabilities	11.91	14.06	3.52	0.57	0.58
Total Current Liabilities	33.29	33.76	19.86	11.95	15.93
Long-Term Leases	3.35	4.3	6.16	8.29	4.74
Long-Term Unearned Revenue	-	-	-	-	1.03
Other Long-Term Liabilities	-	-	-	0.01	1.33
Total Liabilities	36.65	38.06	26.02	20.25	23.02
Additional Paid-In Capital	532.17	530	4.64	1.71	0.53
Retained Earnings	-308.16	-263.52	-136.04	-75.68	-46.78
Comprehensive Income & Other	-0	0.11	0	-0.03	-
Total Common Equity	224.01	266.59	-131.4	-74	-46.25
Shareholders' Equity	224.01	266.59	49.18	46.68	62.47
Total Liabilities & Equity	260.66	304.65	75.2	66.92	85.49
Total Debt	6.94	8.24	9.08	10.56	5.56
Net Cash (Debt)	235.71	277.74	48.46	40.76	70.51
Net Cash Growth	386.36%	473.08%	18.91%	-42.20%	-
Net Cash Per Share	5.46	7.25	71.95	89.48	265.19
Filing Date Shares Outstanding	43.22	43.21	43.12	0.55	0.27
Total Common Shares Outstanding	43.22	43.21	1.25	0.55	0.27
Working Capital	214.36	256.85	40.81	41.3	61.16
Book Value Per Share	5.18	6.17	-105.11	-133.91	-173.96
Tangible Book Value	224.01	266.59	-131.4	-74	-46.25
Tangible Book Value Per Share	5.18	6.17	-105.11	-133.91	-173.96
Machinery	-	6.2	4.17	3.74	3.35
Leasehold Improvements	-	0.82	0.65	0.46	0.08

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q